Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-04

Clinical Trial Update: Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Enstilar in combination with Enbrel or Humira for plaque psoriasis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)
  • Enstilar (calcipotriene; betamethasone dipropionate)
  • Humira (adalimumab)

Snippet

Sponsor: Psoriasis Treatment Center of Central New Jersey | Conditions: Psoriasis | Phase 4 | Status: RECRUITING